“…This percentage is higher than that reported in studies performed in the UK, China, and the USA, which varied from 3.4 to 6% (Bianchi and Lo, 2001;Finning et al, 2008). This is probably due to the heterogeneous genetic profile of the Brazilian population, which raises the possibility that different variants, rare in other populations, prevent the amplification of some exons by mismatching of primers and/or probes with their targeted genomic regions (Rodrigues et al, 2002). Therefore, in ad-mixed populations in which a high variety of RHD alleles is expected, fetal RHD genotyping may lead to false-negative results and may hinder the proper management of RhD-negative pregnant women.…”